Assay
PGDB_AS001028
System: cell_basedTarget: IKZF3Cell line: primary human PBMC
Assay context summary
Assay context
Activity compounds and values
Activity records
| Structure | Metric | Control | Relation | Value | Unit | Concentration | Time | Target | E3 | Cell line | Patent | Record ID | Compound | Assay | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % Degradation | - | = | 67 | % | Concentration context: titrated doses | 24 h | - | - | primary human PBMC | WO2025049840 | PGDB_A008684 | PGDB_C010127 | PGDB_AS001028 | View | |
| % Degradation | - | = | 58 | % | Concentration context: titrated doses | 24 h | - | - | primary human PBMC | WO2025049840 | PGDB_A017639 | PGDB_C010126 | PGDB_AS001028 | View | |
| % Degradation | - | = | 77 | % | Concentration context: titrated doses | 24 h | - | - | primary human PBMC | WO2025049840 | PGDB_A018488 | PGDB_C010128 | PGDB_AS001028 | View | |
| % Degradation | - | = | 76 | % | Concentration context: titrated doses | 24 h | - | - | primary human PBMC | WO2025049840 | PGDB_A037494 | PGDB_C010125 | PGDB_AS001028 | View | |
| % Degradation | - | = | 0 | % | Concentration context: titrated doses | 24 h | - | - | primary human PBMC | WO2025049840 | PGDB_A044758 | PGDB_C007373 | PGDB_AS001028 | View | |
| % Degradation | - | = | 80 | % | Concentration context: titrated doses | 24 h | - | - | primary human PBMC | WO2025049840 | PGDB_A053490 | PGDB_C007372 | PGDB_AS001028 | View | |
| % Degradation | - | = | 72 | % | Concentration context: titrated doses | 24 h | - | - | primary human PBMC | WO2025049840 | PGDB_A054638 | PGDB_C010129 | PGDB_AS001028 | View |